SCHEMBL5668014

SCHEMBL5668014

O=C(O)Cc1ccc(-n2cncn2)nc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.50
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
GABRP O00591 1/20 0.47
GABRD O14764 1/20 0.47
GABRA1 P14867 1/20 0.47
GABRB1 P18505 1/20 0.47
GABRG2 P18507 1/20 0.47
GABRB3 P28472 1/20 0.47
GABRA5 P31644 1/20 0.47
GABRA3 P34903 1/20 0.47
GABRA2 P47869 1/20 0.47
GABRB2 P47870 1/20 0.47
GABRA4 P48169 1/20 0.47
GABRE P78334 1/20 0.47
GABRA6 Q16445 1/20 0.47
GABRG1 Q8N1C3 1/20 0.47
GABRG3 Q99928 1/20 0.47
GABRQ Q9UN88 1/20 0.47
P4HTM Q9NXG6 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26971046 0.81 MAPT (0.48) MAPTMEN1KMT2AKDM4EPOLB
SCHEMBL2657909 0.78 QPCT (0.56) MAPTKDM4EPOLBHTTALDH1A1
SCHEMBL17924368 0.78 MEN1 (0.46) MAPTMEN1KMT2AKDM4EPOLB
SCHEMBL10162131 0.78 MAPT (0.48) MAPTMEN1KMT2AKDM4EPOLB
SCHEMBL600130 0.77 MAPT (0.64) MAPTMEN1KMT2AGABRPGABRD
SCHEMBL2729427 0.77 KCNJ1 (0.58) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL28896722 0.77 LMNA (0.62) MEN1KMT2AGABRPGABRDGABRA1
SCHEMBL28408444 0.75 EGLN1 (0.47) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL10130876 0.75 MAPT (0.42) MAPTMEN1KMT2AKDM4EPOLB
SCHEMBL28823761 0.73 NAMPT (0.52) KMT2AGABRPGABRDGABRA1GABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1471923-A4 AMIDO MACROLIDES KOSAN BIOSCIENCES INC (US) 2006-01-11 EP disclosed
US-6939861-B2 Amido macrolides KOSAN BIOSCIENCES, INC. (US) 2005-09-06 US disclosed
EP-1471923-A1 AMIDO MACROLIDES Kosan Biosciences, Inc. (US) 2004-11-03 EP disclosed
US-20030199458-A1 Amido macrolides KOSAN BIOSCIENCES, INC. 2003-10-23 US disclosed
WO-2003061671-A1 AMIDO MACROLIDES KOSAN BIOSCIENCES, INC. (US) 2003-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199458-A1 Amido macrolides PCSK9, ABCB4, PCSK7 MAPT 4657/4885MEN1 2706/4885KMT2A 4559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.